CAM
BIIB icon

Centre Asset Management’s Biogen BIIB Stock Holding History

Centre Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$7.79M Buy
56,894
+5,364
+10% +$767K 2% 23
2024
Q4 		$7.88M Buy
51,530
+3,698
+8% +$624K 1.8% 30
2024
Q3 		$9.27M Buy
+47,832
New +$10M 2% 31
2023
Q3 		– Sell
-34,686
Closed -$9.88M – 72
2023
Q2 		$9.88M Buy
34,686
+945
+3% +$281K 2.18% 12
2023
Q1 		$9.38M Buy
33,741
+538
+2% +$149K 2.27% 9
2022
Q4 		$9.2M Sell
33,203
-2,383
-7% -$673K 2.43% 10
2022
Q3 		$9.5M Buy
+35,586
New +$7.56M 2.62% 10
2015
Q3 		– Sell
-38,490
Closed -$15.5M – 94
2015
Q2 		$15.5M Sell
38,490
-2,470
-6% -$991K 2.45% 5
2015
Q1 		$17.3M Buy
40,960
+2,070
+5% +$816K 2.57% 5
2014
Q4 		$13.2M Buy
38,890
+15,200
+64% +$4.92M 2.05% 10
2014
Q3 		$7.84M Buy
23,690
+8,130
+52% +$2.68M 1.2% 31
2014
Q2 		$4.91M Sell
15,560
-24,150
-61% -$7.27M 0.74% 67
2014
Q1 		$12.1M Buy
39,710
+1,710
+5% +$543K 1.79% 14
2013
Q4 		$10.6M Buy
38,000
+830
+2% +$215K 1.65% 18
2013
Q3 		$8.95M Buy
37,170
+1,590
+4% +$356K 1.42% 26
2013
Q2 		$7.66M Buy
+35,580
New +$7.6M 1.25% 29

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Centre Asset Management's BIIB Position: Q1 2025 in Review

Centre Asset Management increased its Biogen (BIIB) stake by 10% in Q1 2025, buying an estimated $767K and bringing the position to 56,894 shares worth $7.79M. The position accounts for 2% of the portfolio, ranked #23.

Centre Asset Management first reported a position in BIIB in Q2 2013 and has held it in 16 quarters since. The position peaked at $17.3M in Q1 2015. 880 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

  • Centre Asset Management held 56,894 shares of Biogen worth $7.79M as of Q1 2025.
  • Centre Asset Management bought 5,364 Biogen shares in Q1 2025, an estimated $767K.
  • Biogen made up 2% of Centre Asset Management's portfolio in Q1 2025, its #23 holding.
  • Centre Asset Management first reported a position in Biogen in Q2 2013 and has held it in 16 quarters since.
  • Centre Asset Management's Biogen position peaked at $17.3M in Q1 2015.
  • 880 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Centre Asset Management's 13F filing for Q1 2025, filed 1 Apr 2025.